Drug Shortage Report for AVALIDE

Last updated on 2021-02-06 History
Report ID 132678
Drug Identification Number 02241818
Brand name AVALIDE
Common or Proper name Avalide
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN HYDROCHLOROTHIAZIDE
Strength(s) 150MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-02-05
Actual start date
Estimated end date 2021-03-05
Actual end date
Shortage status Actual shortage
Updated date 2021-02-06
Company comments Production/Shipping Delay The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-02-06 English Compare
v5 2021-01-28 French Compare
v4 2021-01-28 French Compare
v3 2021-01-28 English Compare
v2 2021-01-28 French Compare
v1 2021-01-28 English Compare